2024 Biomedical Pitch Competition Grand Finale Successfully Concludes
We are excited to bring you the grand finale recap of the 2024 Biomedical Pitch Competition, which took place on April 27th at Simcere Boston Innovation Center in Cambridge Discovery Park. This event marked a milestone in the biomedical industry, showcasing the brightest minds and most innovative technologies.
A Meeting of Minds and Innovation
The 2024 Biomedical Pitch Competition, co-organized by the Hong Kong Science and Technology Parks Corporation (HKSTP) and the Boston Chinese Investment Club (BCIC), featured 14 high-caliber teams from the biomedical sector in the final round. These finalists, ranging from early to mid-stage ventures in pharmaceuticals, medical devices, and diagnostics, had the opportunity to present their transformative ideas to a distinguished panel of judges and an audience of industry leaders, investors, and media.
We were honored to have Dr. Grace Lau, Head of Institute for Translational Research and Dr. Weng-Li Yoon, Associate Director, Therapeutics from HKSTP, along with Dr. Qiusong Tang from Roche Accelerator, deliver inspiring keynote addresses. Their speeches highlighted the ongoing efforts and commitments toward accelerating biomedical innovation and fostering a supportive ecosystem for emerging technologies in healthcare.
Dr. Grace Lau from HKSTP
Dr. Qiusong Tang from Roche Accelerator
Our panel of judges included representatives from HKSTP, Roche Accelerator, Kendall Capital Partners, PagodaTree Partners, and LB Ventures. Their deep industry knowledge and critical insights were crucial in selecting the winners among many impressive contenders. Extensive live coverage by leading media partners such as 深蓝观, 赛柏蓝, E药经理人, 药时代, Gene Online, and Page Executive ensured that the event received global attention.
Celebrating the Winners
The competition was fierce, and the innovation displayed was nothing short of remarkable. Congratulations to the winners of this final round:
Competition Results:
| First Prize | GV20 Therapeutics |
| Second Prize | Affinity Biopharma |
| Axcynsis Therapeutics | |
| Third Prize | ImmVira Group: A Novel Payload Deliver |
| Rapafusyn Pharmaceuticals | |
| Cure Genetics Inc. | |
| D2M Biotherapeutics | |
| Innovation Award | Leveragen, Inc. |
| f5 Therapeutics Incorporated | |
| Agilis Robotics Limited | |
| Spark Spine | |
| Azura Bio, Inc. | |
| AI-powered Painless Blood Test Device | |
| NeuronOff, Inc. |
First Prize: GV20 Therapeutics
Second Prize: Axcynsis Therapeutics
Third Prize: Rapafusyn Pharmaceuticals
Third Prize: Cure Genetics Inc.
Third Prize: D2M Biotherapeutics
Innovation Award: Leveragen, Inc.
Innovation Award: Azura Bio, Inc
The success of the 2024 Biomedical Pitch Competition underscores the vibrant potential of the biomedical sector and its significant role in shaping the future of healthcare, attracting more than 17,000 active international viewers through live-streaming portals. We extend our heartfelt congratulations to all participants and winners who have set new benchmarks in innovation.
Stay connected for more updates and breakthroughs from around the world!
Winners & Organizers Group Shot
About Hong Kong Science and Technology Parks Corporation
Hong Kong Science and Technology Parks Corporation (HKSTP) was established in 2001 to create a thriving I&T ecosystem grooming 12 unicorns, more than 14,000 research professionals and over 1,700 technology companies from 27 countries and regions focused on developing healthtech, AI and robotics, fintech and smart city technologies, etc.
Our growing innovation ecosystem offers comprehensive support to attract and nurture talent, accelerate and commercialise innovation for technology ventures, with the I&T journey built around our key locations of Hong Kong Science Park in Shatin, InnoCentre in Kowloon Tong and three modern InnoParks in Tai Po, Tseung Kwan O and Yuen Long realising a vision of new industrialisation for Hong Kong, where sectors including advanced manufacturing, micro-electronics and biotechnology are being reimagined.
Hong Kong Science Park Shenzhen Branch in Futian, Shenzhen plays positive roles in connecting the world and the mainland with our proximity, strengthening cross-border exchange to bring advantages in attracting global talent and allowing possibilities for the development of technology companies in seven key areas: Medtech, big data and AI, robotics, new materials, microelectronics, fintech and sustainability, with both dry and wet laboratories, co-working space, conference and exhibition facilities, and more.
Through our R&D infrastructure, startup support and enterprise services, commercialisation and investment expertise, partnership networks and talent traction, HKSTP continues contribute in establishing I&T as a pillar of growth for Hong Kong.
More information about HKSTP is available at www.hkstp.org.
About Boston Chinese Investment Club (BCIC)
The Boston Chinese Investment Club (BCIC) is a Massachusetts-registered non-profit organization serving nearly 10,000 professionals in finance, venture capital, and various technology industries. Beyond being a Boston-centered platform, the BCIC has grown to facilitate nationwide and international knowledge exchange across healthcare, finance, and related fields. Since 2022, the organization has hosted annual biomedical pitch competitions, empowering startups to secure over $50 million in collective funding.
BCIC boasts a network of global affiliates situated in key locations including Boston, New York, Washington, California, Ohio, Beijing, Shanghai, Chengdu, and Shenzhen, and evolves into a facilitator of nationwide and international knowledge exchange, alongside serving as a hub for integrated business services.
Mission:
Foster communication and discussion among Chinese finance, investment, and R&D and sales companies
Establish a platform for connecting Asia capital and projects
Services:
Provide members with investment and financing, career development, and social networking services
Cultivate talent and provide advice for the development of the investment industry
Branch Offices:
United States: Boston, New York, Washington, California, Ohio
Asia: Beijing, Shanghai, Chengdu, Shenzhen
Members:
Nearly 10,000 members worldwide
From a variety of renowned financial institutions, startups, and industry leaders
Collaborative Services:
Startup Competition: Help early- and mid-stage companies obtain professional guidance, funding, and resources
Business Expansion: Assist mid- and late-stage companies in expanding sales channels, technology mergers and acquisitions (License BD)
Global Expansion: Assist Asian companies in expanding into the North American market and optimizing cross-border supply chains
IPO Advisory: Assist companies in listing on international capital markets and embarking on a new journey of development
Contact Information:
Website: https://bcicglobal.org
Email: info@bcicglobal.org
Event Organizers & Partners List
Disclaimer of Intellectual Property Rights
**All intellectual property rights associated with the pitch competition, including but not limited to the competition format, scoring system, final and semi-final results, and any creative content generated during the competition (pitches, presentations, etc.) are the exclusive property of the Organizers.
Participants grant the Organizers a non-exclusive, worldwide, royalty-free license to use, reproduce, modify, publish, and distribute such intellectual property for promotional purposes related to the competition.
Participants may quote content from winning pitches (3 or more winners) in public reports, provided they clearly attribute the content to the winning team(s) and the competition itself. However, participants must obtain prior written approval from the Organizers if such quotes exceed a reasonable length or misrepresent the content of the pitch.